Publications by authors named "Juan-Carlos Tellez"
Article Synopsis
- The analysis aimed to compare patient outcomes from two large cohorts in Europe and the USA who underwent coronary artery bypass grafting (CABG) to assess the effectiveness of knowledge exchange among cardiovascular surgery societies.
- Data was collected from the European DuraGraft Registry (2,522 patients) and the US STS database (294,725 patients), with both groups undergoing CABG between 2016 and 2019, and factors were matched using propensity score models to ensure fair comparison of outcomes.
- Key findings revealed different patient profiles, with European patients more likely to have left main disease and receive arterial grafts, while US patients tended to have more saphenous vein grafts; however, these differences in treatment approaches were
Objectives: The objective of the European Multicenter Registry to Assess Outcomes in coronary artery bypass grafting (CABG) patients (DuraGraft Registry) was to determine clinical outcomes and quality of life (QoL) after contemporary CABG that included isolated CABG and combined CABG/valve procedures, using an endothelial damage inhibitor (DuraGraft) intraoperatively for conduit preservation. Here, we report outcomes in the patient cohort undergoing isolated CABG.
Methods: The primary outcome was the composite of all-cause death, myocardial infarction (MI), or repeat revascularization (RR) [major adverse cardiac events (MACE)] at 1 year.
Objectives: Left main coronary artery disease (LMCAD) is considered an independent risk factor for clinical events after coronary artery bypass grafting (CABG). We have conducted a subgroup analysis of the multicentre European DuraGraft Registry to investigate clinical event rates at 1 year in patients with and without LMCAD undergoing isolated CABG in contemporary practice.
Methods: Patients undergoing isolated CABG were selected.